FibroBiologics, Inc.
FBLG
$1.06
-$0.09-7.83%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Net Income | 17.66% | -54.13% | 43.86% | -24.04% | 6.20% |
| Total Depreciation and Amortization | -32.07% | 1.28% | 1.30% | 12.14% | 27.95% |
| Total Amortization of Deferred Charges | -- | -- | -- | -100.00% | -- |
| Total Other Non-Cash Items | 5.47% | -45.90% | -22.02% | 371.12% | -70.32% |
| Change in Net Operating Assets | 95.85% | 81.96% | -2,403.45% | 112.11% | 69.20% |
| Cash from Operations | 24.59% | -37.97% | 20.37% | 0.30% | 24.47% |
| Capital Expenditure | -- | -- | 100.00% | 97.18% | -395.35% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | -- | 100.00% | 97.18% | -395.35% |
| Total Debt Issued | -100.00% | -- | -- | -100.00% | -- |
| Total Debt Repaid | -50.62% | 97.62% | -- | -- | -- |
| Issuance of Common Stock | 305.38% | -89.29% | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 459.24% | -70.16% | -- | -100.00% | -- |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 159.58% | -12,737.04% | 100.68% | -2,334.83% | 103.35% |